当前位置:首页 - 行情中心 - 祥生医疗(688358) - 财务分析 - 现金流量表

祥生医疗

(688358)

  

流通市值:38.71亿  总市值:38.76亿
流通股本:1.12亿   总股本:1.12亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金85,825,240.41434,507,555.85323,526,251.41214,839,726.77
  收到的税费返还6,085,492.9927,853,696.124,160,075.3412,479,795.96
  收到其他与经营活动有关的现金20,407,033.739,502,054.8226,391,904.0815,213,442.82
  经营活动现金流入小计112,317,767.1501,863,306.77374,078,230.83242,532,965.55
  购买商品、接受劳务支付的现金70,912,394.13205,231,590.34139,883,510.9482,668,074.29
  支付给职工以及为职工支付的现金36,710,268.64126,620,632.694,581,881.567,540,493.3
  支付的各项税费8,380,729.7520,337,022.8420,277,452.0213,477,688.21
  支付其他与经营活动有关的现金13,220,124.5942,505,858.1346,045,103.4625,142,901.37
  经营活动现金流出小计129,223,517.11394,695,103.91300,787,947.92188,829,157.17
  经营活动产生的现金流量净额-16,905,750.01107,168,202.8673,290,282.9153,703,808.38
二、投资活动产生的现金流量:
  收回投资收到的现金200,590,7001,516,516,282.621,278,486,349.35860,658,200
  取得投资收益收到的现金247,493.153,816,784.123,193,084.122,124,549.26
  处置固定资产、无形资产和其他长期资产收回的现金净额-5,570,480.924,270,315.313,718,714.53
  收到的其他与投资活动有关的现金1,230,853.145,686,788.225,014,073.393,510,741.51
  投资活动现金流入小计202,069,046.291,531,590,335.881,290,963,822.17870,012,205.3
  购建固定资产、无形资产和其他长期资产支付的现金4,969,935.4414,407,094.2912,760,925.5512,049,589.94
  投资支付的现金69,678,0001,459,359,882.621,250,535,421.36843,552,100
  投资活动现金流出小计74,647,935.441,473,766,976.911,263,296,346.91855,601,689.94
  投资活动产生的现金流量净额127,421,110.8557,823,358.9727,667,475.2614,410,515.36
三、筹资活动产生的现金流量:
  吸收投资收到的现金-3,735,750--
  筹资活动现金流入平衡项目-0--
  筹资活动现金流入小计-3,735,750--
  分配股利、利润或偿付利息支付的现金33,637,683.9111,874,753111,874,753-
  支付其他与筹资活动有关的现金473,853.794,398,999.674,116,634.671,990,208.2
  筹资活动现金流出小计34,111,537.69116,273,752.67115,991,387.671,990,208.2
  筹资活动产生的现金流量净额-34,111,537.69-112,538,002.67-115,991,387.67-1,990,208.2
四、汇率变动对现金及现金等价物的影响-12,966,786.29-30,544,053.35-4,939,828.76-3,633,007.03
五、现金及现金等价物净增加额63,437,036.8621,909,505.81-19,973,458.2662,491,108.51
  加:期初现金及现金等价物余额840,572,827.86818,663,322.05818,703,836.07818,663,322.05
  期末现金及现金等价物余额904,009,864.72840,572,827.86798,730,377.81881,154,430.56
补充资料:
  净利润-116,499,752.06-69,696,320.88
  资产减值准备-4,314,477.93-2,501,971.97
  固定资产和投资性房地产折旧-9,147,146.72-5,508,480.04
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-9,147,146.72-5,508,480.04
  无形资产摊销-1,373,825.57-521,317.64
  长期待摊费用摊销-893,119.15-120,903.9
  处置固定资产、无形资产和其他长期资产的损失--4,525,956.56--3,156,901.27
  公允价值变动损失----95,763.77
  财务费用-11,446,093.17--1,319,547.47
  投资损失--3,429,755.01--1,953,564.51
  递延所得税--2,733,516.05--455,259.97
  其中:递延所得税资产减少--2,733,516.05--455,259.97
  存货的减少--7,029,025.22-9,058,375.24
  经营性应收项目的减少--35,678,578.26--27,477,098.85
  经营性应付项目的增加-12,051,360.47--4,004,611.99
  其他--56,186.2-1,168,258.51
  现金的期末余额-840,572,827.86-881,154,430.56
  减:现金的期初余额-818,663,322.05-818,663,322.05
  现金及现金等价物的净增加额-21,909,505.81-62,491,108.51
公告日期2026-04-282026-04-202025-10-202025-08-29
审计意见(境内)标准无保留意见
TOP↑